¿Qué es la encefalitis anti-NMDAR? | 16 ABR 18

Psicosis de inicio súbito en Emergencias, ¿cómo actuar?

A partir de una viñeta clínica se analizan los criterios de diagnóstico de una patología frecuentemente no diagnosticada

Autor/a: Daniel Lasoff, MD, Gary Vilke, MD, Kimberly Nordstrom, MD and Michael Wilson, MD, PHD DETECTION AND MANAGEMENT OF ANTI-METHYL-D-ASPARATE RECEPTOR ENCEPHALITIS

INDICE: 1. Página 1 | 2. Página 1

Página 1

1. Dalmau J, Tu¨zu¨n E, Wu HY, et al. Paraneoplastic anti–N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36.
2. Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-Nmethyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull 2015;39:19–23.
3. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–8.
4. Florance NR, Davis RL, Lam C, et al. AntiN-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11–8.
5. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655–67.
6. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54:899–904.
7. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10: 63–74.
8. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866–75.
9. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009;28:1421–9.
10. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–65.
11. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012;79:1094– 100.
12. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010;75:1480–2.
13. Wang R, Guan HZ, Ren HT, Wang W, Hong Z, Zhou D. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure 2015;29:137–42.
14. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. AntiNMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011;231:86–91.
15. Punja M, Pomerleau AC, Devlin JJ, Morgan BW, Schier JG, Schwartz MD. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium. Clin Toxicol 2013;51:794–7.
16. Sabin TD, Jednacz JA, Staats PN. Case 26-2008: a 26-year-old woman with headache and behavioral changes. N Engl J Med 2008;359:842–53.
17. Iizuka T, Sakai F, Dalmau J, et al. Anti-NMDA receptor encephalitis in Japan long-term outcome without tumor removal. Neurology 2008;70:504–11.
18. Pruss H, Dalmau J, Wandinger KP, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010;75:1735–9.